Current Ratio of Stoke Therapeutics, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Stoke Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Stoke Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 697%, a 17% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Stoke Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 697% +100% +17% 30 Sep 2025
Q2 2025 653% -34% -5% 30 Jun 2025
Q1 2025 647% -133% -17% 31 Mar 2025
Q4 2024 574% -305% -35% 31 Dec 2024
Q3 2024 597% -304% -34% 30 Sep 2024
Q2 2024 687% -215% -24% 30 Jun 2024
Q1 2024 780% -115% -13% 31 Mar 2024
Q4 2023 879% -117% -12% 31 Dec 2023
Q3 2023 901% -228% -20% 30 Sep 2023
Q2 2023 903% -441% -33% 30 Jun 2023
Q1 2023 895% -835% -48% 31 Mar 2023
Q4 2022 997% -1334% -57% 31 Dec 2022
Q3 2022 1128% -1728% -60% 30 Sep 2022
Q2 2022 1343% -1813% -57% 30 Jun 2022
Q1 2022 1730% -1496% -46% 31 Mar 2022
Q4 2021 2330% -765% -25% 31 Dec 2021
Q3 2021 2856% -958% -25% 30 Sep 2021
Q2 2021 3157% -1203% -28% 30 Jun 2021
Q1 2021 3226% -1558% -33% 31 Mar 2021
Q4 2020 3096% 31 Dec 2020
Q3 2020 3814% 30 Sep 2020
Q2 2020 4360% 30 Jun 2020
Q1 2020 4785% 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.